When it comes to two plasma donors die at private canadian clinics under federal investigation, two individuals have tragically died after donating plasma at clinics operated by the Spanish healthcare company Grifols in Canada, prompting an investigation by Health Canada. The fatalities, which occurred in October 2025 and January 2026, have raised serious concerns about the safety practices at these facilities, which have faced scrutiny for record-keeping and donor screening failures.
Understanding Two Plasma Donors Die At Private Canadian Clinics Under Federal Investigation
The deceased donors, one identified as Rodiyat Alabede, a 22-year-old international student who donated plasma in Winnipeg, went into distress during the donation process. Friends described Alabede as someone who aspired to become a social worker, known for her kindness and compassion. The second fatality occurred at a different Grifols location in Winnipeg just three months later. Health Canada has received reports of these "fatal adverse reactions" and has stated that investigations are ongoing. Originally reported by The Guardian.
Grifols has publicly expressed that it does not believe there is a connection between the plasma donations and the deaths. However, the Canadian Blood Service expressed its deep sadness regarding the incidents, emphasizing its commitment to monitoring donor health and adhering to high safety standards.
Regulatory Oversight and Compliance Issues
Health Canada, the federal agency responsible for regulating plasma clinics, has been conducting inspections of Grifols facilities, particularly in light of deficiencies noted in their operational procedures. One facility in Saskatchewan was cited for failing to accurately assess donor suitability, among other issues. This was one of 11 deficiencies that led to a non-compliant rating under Canada's Food and Drugs Act.
In Alberta, another Grifols clinic was found to have ten deficiencies, including problems with record-keeping and donor screening. Health Canada officials have described these compliance reports as "troubling," suggesting that they reflect deeper concerns about the management of these facilities.
Critics Raise Concerns Over Privatization
Experts and advocates are voicing alarm over Canada's growing reliance on private companies for blood product management. Some critics argue that this trend signifies a "slow collapse of a system that has been the envy of the world." The Canadian Hemophilia Society's British Columbia chapter president, Curtis Brandell, highlighted his shock upon learning about the deaths, noting that one death would be unexpected, but two raises serious alarm bells.
Brandell and others advocate for stricter regulations and oversight of plasma donation centers, emphasizing the need for public accountability in the handling of such critical health resources. The fact that these private clinics are allowed to operate amid ongoing compliance concerns has drawn ire from various health and safety advocates.
Grifols Responds to Criticism
In response to the scrutiny, Grifols has committed to addressing the identified deficiencies. The company stated, "A 'non-compliant' rating means that the identified operational processes require improvement and we are working hard to address those swiftly." Officials maintain that every donor undergoes a thorough health history evaluation and physical examination before being deemed eligible to donate.
Following the incidents, Grifols has submitted detailed action plans to Health Canada, aimed at preventing further occurrences and improving compliance with safety standards. The facilities in Calgary and Regina remain operational while these corrective measures are implemented.
Despite the company's assurances, the series of reported non-compliance incidents raises questions about the ongoing safety of plasma donation practices in Canada. With Grifols accounting for half of the eight documented instances of non-compliance since 2016, the call for improved oversight continues to grow.
The deaths of the two plasma donors serve as a stark reminder of the importance of rigorous safety protocols in healthcare settings. As investigations unfold, the focus will remain on ensuring the safety and well-being of all individuals participating in plasma donation and the subsequent handling of these critical health resources.
Originally reported by The Guardian. View original.